Title : Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive-compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study.

Pub. Date : 2022 Jan 31

PMID : 35105633






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The primary objective of this study is to determine the efficacy of the COX-2-selective inhibitor celecoxib as an adjunct to treatment-as-usual in children and youth with moderate-to-severe OCD. Celecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens